abstract |
The present invention relates to a method for identifying urokinase-type plasminogen activator (uPA) antibodies. The invention also relates to antibodies that can bind uPA and reduce or inhibit uPA activity. The invention further relates to the use for such antibodies, such as therapeutic and pharmaceutical uses. |